Evidence map›Paper›PMID 39286295›Full record

ArticleClinical and translational imaging2024

Is there a role for [

Khrishanthne Sambasivan, Sally F Barrington, Steve Ej Connor, Timothy H Witney, Philip J Blower, Teresa Guerrero Urbano

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Clinical and translational imaging, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Khrishanthne SambasivanDepartment of Clinical Oncology, Guy's and St Thomas' NHS Foundation Trust, London, UK; School of Biomedical Engineering and Imaging Sciences, King's College London, London, United Kingdom.ORCID https://orcid.org/0000-0002-2738-1785
Sally F BarringtonKing's College London and Guy's and St Thomas' PET Centre; School of Biomedical Engineering and Imaging Sciences, King's College London, King's Health Partners, London, UK.
Steve Ej ConnorDepartment of Neuroradiology, King's College Hospital NHS Foundation Trust, London, UK Department of Radiology, Guy's and St Thomas' NHS Foundation Trust, London, UK; School of Biomedical Engineering and Imaging Sciences, St Thomas' Hospital, King's College London, London, UK.
Timothy H WitneyKing's College London, School of Biomedical Engineering and Imaging Sciences, St Thomas' Hospital, London, United Kingdom.
Philip J BlowerKing's College London, School of Biomedical Engineering and Imaging Sciences, St Thomas' Hospital, London, United Kingdom.
Teresa Guerrero UrbanoDepartment of Clinical Oncology, Guy's and St Thomas' NHS Foundation Trust, London, UK; Faculty of Dentistry, Oral & Craniofacial Sciences and School of Cancer & Pharmaceutical Sciences, King's College London, London, United Kingdom.

Funding

Wellcome Trust
6 · The paper itself

Abstract

Purpose: Hypoxia is a major cause of radioresistance in head and neck cancer (HNC), resulting in treatment failure and disease recurrence. Methods: A comprehensive literature search was conducted on PubMed and Web of Science databases. Studies investigating [ Results: We found the following important results from our literature review: 1)Studies have focussed on comparing [ Conclusions: Our results suggest it is unlikely [

Indexed as

[18F]FMISOhead and neck cancerhypoxia

Identifiers

PMID39286295
PMCPMC7616449

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.